Open original FDA record ↗Recall record
- FDA identifier
- Z-2306-2021
- Company in FDA record
- Philips Ultrasound Inc
- FDA record creation date
- Aug 16, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Ultrasound system control panel arm swivel lock could fail, which could cause the control panel and monitor to swivel freely while a user is positioning the monitor, or transporting/moving the system, which could lead to patient or user musculoskeletal injury.
Source facts
- Action
- Medical device correction notices were mailed to customers who were asked to take the following actions to prevent risks for patients or users: When Positioning or Transporting/Moving the EPIQ Ultrasound System: A) Prior to positioning or transporting/moving the system, ensure the control panel locking mechanism is engaged to prevent the control panel and monitor from swiveling freely. B) To ensure the control panel locking mechanism is working properly: 1. Engage the system brake. 2. Observe the lock/unlock button on the system handle. It should not be illuminated. 3. If it is illuminated press button to lock arm. Illumination should cease and arm should lock. 4. Using the system handle, attempt to rotate the control panel. If the control panel does not rotate, the system is locked and ready to be transported/moved. 5. Release the brake and transport/move the system as needed. C) Do not make any twisting or sudden motions with the control panel when adjusting or steering the system. D) When transporting/moving the system, push from behind using the back handles on the control panel. Additional information can be obtained from your local service representative: 1-800-722-9377 Complete and return the response form.
- Initiated
- 2021-07-22
- Root cause
- Device Design
- Distribution
- Worldwide distribution - US Nationwide distribution including in the states of FL, UT, CA, CO, WA, MS, NC, NV, GA, LA, VA, SC, NE, TN, HI, OR, ID, MI, OH, IN, IL, OK, TX, PA, NJ, CT, NY, DE, SD, WI, VT, MN, KS, MO, KY, MA, NH, IA, MT, NM, ME, AZ, AR, AL, WY, ND, AK, MD, RI, WV, DC, VI and the countries of Argentina, Australia, Bahrain, Peru, Serbia, Bolivia, Moldova, Albania, Ukraine, Uruguay, Belarus, Hungary, Greece, Honduras, Montenegro, Senegal, Brazil, Bulgaria, Canada, Chile, Colombia, Costa Rica, Cyprus, Dominican Republic, Germany, Ecuador, Estonia, Finland, Taiwan, Georgia, United Kingdom, Guatemala, Hong Kong, Indonesia, Iran, Israel, Yemen, Jordan, Korea, Republic of, Latvia, Lebanon, Libya, Lithuania, Macedonia, Malta, Morocco, Mauritius, Nicaragua, New Zealand, Norway, Oman, United Arab Emirates, Austria, Panama, Poland, Portugal, Qatar, Russian Federation, Saudi Arabia, Thailand, Czech Republic, Tunisia, Uzbekistan, South Africa, Sweden, Switzerland, Netherlands, France, Monaco, Martinique, New Caledonia, Italy, China, India, Denmark, Singapore, Belgium, Spain, Mexico, Viet Nam, Philippines, Malaysia, Japan, Bangladesh, Ireland, Luxembourg, Andorra, Nepal, Myanmar, Pakistan, Brunei Darussalam, French Guiana, Sri Lanka, Kazakhstan, Egypt, Turkey, Kuwait, Romania, Slovakia, Croatia, Slovenia, Bosnia and Herzegovina.
- Recall number
- Z-2306-2021
- Recall status
- Completed
- CDRH record ID
- 188369
- FDA record created
- 2021-08-16
- Recall event number
- 88313